CooperCompanies Q3: Strong Performance, New Product Launches

CooperCompanies Q3 results met expectations, with a 4.6% revenue increase to $1.07 billion. The companys premium daily contact lens business and new contracts drove growth. CEO Al White attributed success to the MyDay lens line, particularly the MyDay Energous lens. Despite Asia Pacific weakness, CooperVisions growth was fueled by better product availability and new product releases. CooperSurgicals fertility products and PARAGARD device gained market share and demand. Adjusted earnings per share beat estimates by 3.3%. For Q4, CooperCompanies projects revenue of $1.02 billion and adjusted earnings per share of $4.53 for 2026, beating current estimates by 3.2%. Analysts are watching new product launches and a strategic review to maximize shareholder value.The Daily News Now! — Every city. Every story. AI-powered. Hosted on Acast. See acast.com/privacy for more information.